E-ISSN 2983-757X Open Access · Peer-reviewed
Home › Journal of Research in Veterinary Sciences 2026, Vol: 6, Issue: 4
« Previous Article
Next Article »

Case Report
Online Published: 12 Nov 2026
 


Equine Influenza Antibodies In Argentine Polo Ponies Imported from the United Kingdom Into Nigeria: a Case for Transboundary Animal Disease Monitoring

Judith Dizot Bakam, Nicodemus Mkpuma, Richard Edeh, Felix Idoko, Olayinka Asala, Clement Meseko.


Abstract
Abstract
Equine influenza virus (EIV) continues to threaten equine health and the global horse industry despite widespread vaccination. International movement of horses is a major driver of viral dissemination, increasing the risk of transboundary introduction into previously unaffected regions. Here, we report the detection of EIV antibodies in six vaccinated polo ponies imported from the United Kingdom into Nigeria during routine post-import screening. Five horses were clinically healthy on arrival, whereas one of the horses displayed mild respiratory clinical signs. Serological analysis using a nucleoprotein enzyme-linked immunosorbent assay (NP-ELISA) detected antibodies in all animals, consistent with vaccine-induced immunity or prior exposure. The study underscores the importance of quarantine, surveillance, and post-import monitoring as critical components of equine biosecurity. Strengthening quarantine frameworks and incorporating molecular diagnostics into import protocols will improve early detection and reduce the risk of global EIV spread.

Key words: Equine, Influenza, Surveillance


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Judith Dizot Bakam
Articles by Nicodemus Mkpuma
Articles by Richard Edeh
Articles by Felix Idoko
Articles by Olayinka Asala
Articles by Clement Meseko
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Bakam JD, Mkpuma N, Edeh R, Idoko F, Asala O, Meseko C. Equine Influenza Antibodies In Argentine Polo Ponies Imported from the United Kingdom Into Nigeria: a Case for Transboundary Animal Disease Monitoring. J Res Vet Sci. 2026; 6(4): 382-386. doi:10.5455/JRVS.20260206042221


Web Style

Bakam JD, Mkpuma N, Edeh R, Idoko F, Asala O, Meseko C. Equine Influenza Antibodies In Argentine Polo Ponies Imported from the United Kingdom Into Nigeria: a Case for Transboundary Animal Disease Monitoring. https://www.wisdomgale.com/jrvs/?mno=309582 [Access: November 18, 2026]. doi:10.5455/JRVS.20260206042221


AMA (American Medical Association) Style

Bakam JD, Mkpuma N, Edeh R, Idoko F, Asala O, Meseko C. Equine Influenza Antibodies In Argentine Polo Ponies Imported from the United Kingdom Into Nigeria: a Case for Transboundary Animal Disease Monitoring. J Res Vet Sci. 2026; 6(4): 382-386. doi:10.5455/JRVS.20260206042221



Vancouver/ICMJE Style

Bakam JD, Mkpuma N, Edeh R, Idoko F, Asala O, Meseko C. Equine Influenza Antibodies In Argentine Polo Ponies Imported from the United Kingdom Into Nigeria: a Case for Transboundary Animal Disease Monitoring. J Res Vet Sci. (2026), [cited November 18, 2026]; 6(4): 382-386. doi:10.5455/JRVS.20260206042221



Harvard Style

Bakam, J. D., Mkpuma, . N., Edeh, . R., Idoko, . F., Asala, . O. & Meseko, . C. (2026) Equine Influenza Antibodies In Argentine Polo Ponies Imported from the United Kingdom Into Nigeria: a Case for Transboundary Animal Disease Monitoring. J Res Vet Sci, 6 (4), 382-386. doi:10.5455/JRVS.20260206042221



Turabian Style

Bakam, Judith Dizot, Nicodemus Mkpuma, Richard Edeh, Felix Idoko, Olayinka Asala, and Clement Meseko. 2026. Equine Influenza Antibodies In Argentine Polo Ponies Imported from the United Kingdom Into Nigeria: a Case for Transboundary Animal Disease Monitoring. Journal of Research in Veterinary Sciences, 6 (4), 382-386. doi:10.5455/JRVS.20260206042221



Chicago Style

Bakam, Judith Dizot, Nicodemus Mkpuma, Richard Edeh, Felix Idoko, Olayinka Asala, and Clement Meseko. "Equine Influenza Antibodies In Argentine Polo Ponies Imported from the United Kingdom Into Nigeria: a Case for Transboundary Animal Disease Monitoring." Journal of Research in Veterinary Sciences 6 (2026), 382-386. doi:10.5455/JRVS.20260206042221



MLA (The Modern Language Association) Style

Bakam, Judith Dizot, Nicodemus Mkpuma, Richard Edeh, Felix Idoko, Olayinka Asala, and Clement Meseko. "Equine Influenza Antibodies In Argentine Polo Ponies Imported from the United Kingdom Into Nigeria: a Case for Transboundary Animal Disease Monitoring." Journal of Research in Veterinary Sciences 6.4 (2026), 382-386. Print. doi:10.5455/JRVS.20260206042221



APA (American Psychological Association) Style

Bakam, J. D., Mkpuma, . N., Edeh, . R., Idoko, . F., Asala, . O. & Meseko, . C. (2026) Equine Influenza Antibodies In Argentine Polo Ponies Imported from the United Kingdom Into Nigeria: a Case for Transboundary Animal Disease Monitoring. Journal of Research in Veterinary Sciences, 6 (4), 382-386. doi:10.5455/JRVS.20260206042221



Introduction

Horses, which are used for transportation, agricultural work, sports and racing, shows and tourism, and therapeutic interventions, may serve as sources of transmissible diseases [1]. Equine influenza virus (EIV) is known to cause a highly contagious and virulent equid respiratory disease, known as Equine Influenza (EI). EIV epidemics cause severe illness in horses and donkeys, leading to economic losses for breeders, racing horse owners, and governments. It poses a global threat to equines [2-4]. Other animals such as dogs, cats, and humans are also susceptible [4,5]. Due to its segmented genome, EIV exhibits significant antigenic variability, complicating long-term disease control efforts, especially through vaccination [4]. These are Type A influenza viruses primarily associated with two subtypes, H3N8 and H7N7, which are believed to have avian influenza virus ancestry. The H3N8 subtype circulates widely, but the H7N7 subtype is considered extinct [6]. Equine influenza A virus has impacted the equine industry internationally because of its high morbidity and mortality. The virus is readily transmitted through direct contact and inhalation, facilitating its global dissemination and resulting in outbreaks worldwide over the past decade [7]. The three most common signs of equine influenza are a persistent, harsh, dry cough, pyrexia, often exceeding 39-41°C when at its peak, and a serous and subsequently mucopurulent nasal discharge in naive horses. Other clinical signs include depression, anorexia, myalgia, limb oedema and enlarged mandibular lymph nodes.  Vasculitis, myositis, and myocarditis may occur but are infrequent complications of EIV infection [8,9].

Despite routine vaccination programs, outbreaks still occur, often associated with the movement of apparently healthy horses across borders. This report documents the detection of equine influenza virus antibodies in vaccinated mares imported from the United Kingdom during routine screening. It emphasizes the importance of quarantine and surveillance protocols in preventing the introduction of infectious agents into new regions.

Case presentation

A group of six polo ponies were imported from the United Kingdom (11th September, 2025) to Nigeria (12th September, 2025) for polo purposes. The flight from the UK to Nigeria took about 9 hours. After landing in Lagos, the journey to Jos took two additional days, including an overnight stop in Keffi. The animals were aged 7, 9, 9, 10, 11, and 16 years, and had been vaccinated against equine influenza (inactivated adjuvanted subunit vaccine) prior to shipment. The vaccination history spanned from 10 July 2023 to 17 August 2025. The owner requested routine post-import screening, with specific emphasis on equine influenza. Five out of the six horses were clinically healthy upon arrival. Vital parameters, including temperature, respiratory rate, and heart rate, were within normal ranges, and no nasal discharge, coughing, or other respiratory signs were observed. However, one pony (7 years old) showed congested ocular mucous membranes, mild cough, unilateral mucoid nasal discharge, temperature 38.9°C, and dullness.

Diagnostic assessment

During the initial examination, five of the six horses appeared healthy, while one exhibited mild signs suggestive of a possible respiratory illness. To better understand their exposure to EIV, nasopharyngeal swabs and blood samples were collected from all six horses and sent to the Regional Laboratory for Animal Influenza and Transboundary Animal Diseases, Vom, Plateau State, Nigeria. Upon arrival at the laboratory, nasopharyngeal swab samples underwent RNA extraction and were subsequently screened for the avian influenza virus (AIV) matrix (M) gene using the QuantiTect Multiplex RT-PCR Kit (Qiagen). Serological testing using a Nucleoprotein Enzyme-Linked Immunosorbent Assay (NP-ELISA), a commercially available ELISA from (ID.Vet) showed seropositivity in all the animals, suggesting that they had either been previously exposed to the virus or vaccinated, and that all six horses had protective immunity against equine influenza.

Nucleic acid extraction

Total viral RNA was extracted from 140 μl of the nasal swabs (6) using RNA extraction kit (Qiagen, Germany), according to the manufacturer’s protocol and eluted in 60 μl of RNase-free water. The RNAs were used immediately for real-time reverse transcription polymerase chain reaction (RT-qPCR).

RT‐qPCR

Extracted viral nucleic acids were screened for the Avian Influenza Virus (AIV) Matrix gene using the Qiagen® QuantiTect Multiplex RT-PCR Kit, as previously described by [10]. This protocol amplifies different regions within the matrix (M) gene, which is well conserved among influenza A viruses of all subtypes. 

Table 1. Result for polymerase chain reaction

SAMPLE ID

RT-qPCR (M-gene)

VRD/25/158A

Negative

VRD/25/158B

Negative

VRD/25/158C

Negative

VRD/25/158D

Negative

VRD/25/158E

Negative

VRD/25/158F

Negative

ELISA Test Procedure

All the reagents were allowed to reach room temperature and were mixed thoroughly to ensure complete homogenization. Briefly, the ELISA test procedure involved adding 90µl of diluent 2 to wells A1, B1, C1, and D1, while 200µl was added to the remaining wells using a micropipette. Then, 10µl of the positive control was added to wells A1 and B1, followed by 10µl of the negative control to wells C1 and D1. Then, 5µl of each sample to be tested was added to the remaining wells. The plate was covered and incubated for 60 min ± 5 min at 37ºC (± 2ºC). The wells were emptied, and each was washed five times with approximately 300µl of wash solution. Drying of wells between washings was avoided. The conjugate 1x was prepared by diluting the concentrated conjugate 10x to a 1/10 concentration in dilution buffer 3. Afterwards, 50µl of the conjugate 1x was added to each well. Incubation was achieved by covering the plate and incubating for 30 min ± 2 min at 21ºC (± 5ºC). Washing was done by washing each well 3 times with approximately 300µl of wash solution. Again, 50µl of the substrate solution was added to each well. The plate was covered and incubated once more for 10 min ± 1 min at 21ºC (± 5ºC) in the dark. Finally, 50µl of the stop solution was added to each well in order to stop the reaction. The optical density (OD) was measured and recorded at 450nm. Test samples with an optical density < 45% of the mean of the negative controls were considered positive for IAV antibodies, whereas those with an optical density ≥ 45% were declared negative.

Table 2. ELISA Result based on percentage of inhibition

Sample ID

Inhibition %

EQ1

5.38%

EQ2

4.94%

EQ3

5.38%

EQ4

6.38%

EQ5

6.01%

EQ6

5.32%

Disease management

Rapid diagnosis, movement restrictions and vaccination are the key control measures for equine influenza [8]. Supportive and antimicrobial therapies were administered to manage the horse. Flunixin meglumine (Flunifield®; Chinfield, Argentina) was administered intravenously at a dose of 1.1 mg/kg once daily for three days. Additionally, a long-acting penicillin–streptomycin combination (Penstrep-400® LA; Interchemie, Holland), containing benzathine penicillin G and streptomycin, was administered intramuscularly at doses of 10,000 IU/kg and 10 mg/kg, respectively, every 72 hours for five days. In addition, rest in a dust-free environment was an essential component of the management of this case [11]. Movement restrictions were implemented to successfully reduce the risk of outbreaks in susceptible populations [12]. Clinical signs resolved within 5 days of treatment using antibiotics and anti-inflammatories. The case resolved after five days of treatment, with no further episodes observed. Significant clinical improvement was noted from the third day of treatment.

Disease prevention and control

The spread of equine influenza is driven by international horse movement; prevention and control rely on biosecurity, vaccination, and surveillance [4,8]. Quarantine stringency for equine influenza varies globally, stricter biosecurity in countries such as Australia and New Zealand has prevented endemic disease [8,13]. Vaccination is an important measure for the control of EIV. The Expert Surveillance Panel on Equine Influenza Vaccine Composition of the World Organization for Animal Health (WOAH) annually reviews circulating EIVs and recommends appropriate vaccine strains to ensure vaccine efficacy [14]. 

Discussion

The international movement of horses is a significant route for the transboundary spread of infectious diseases, including equine influenza virus (EIV) [15,16]. In this case, ELISA detected EIV antibodies in six vaccinated polo ponies imported from the United Kingdom into Nigeria during routine post-import screening. Five ponies were clinically healthy at the time of sampling, while one was clinically unhealthy. All six horses had documented vaccination histories against equine influenza. Given their vaccination status and the absence of virological or quantitative serological evidence of recent infection, these antibody findings are consistent with vaccine-induced immunity. However, natural infection cannot be excluded based solely on the qualitative serological results.

The detection of antibodies does not confirm active infection, vaccine failure, or viral shedding. Vaccination reduces the severity of clinical disease but does not necessarily prevent infection after exposure to EIV [16,17]. Vaccinated horses may therefore become infected and, in some circumstances, shed virus. In the present case, however, there was no evidence of viral RNA, virus isolation, or any other direct evidence of viral shedding. Similarly, the clinical signs observed in the unhealthy pony cannot be attributed to EIV based only on the detection of antibodies. These considerations are crucial when interpreting serological results from vaccinated horses and assessing the risk associated with the international movement of horses.

International transport may increase exposure to respiratory pathogens because horses from different geographical and immunological backgrounds may come into contact at sales yards, shipping facilities, quarantine stations, and during transit. Transport-related stress may further increase susceptibility to respiratory infections, including EIV [17-19]. These factors support the continued use of quarantine and post-import health monitoring for horses entering new equine populations.

The vaccination records indicated that some horses had received their most recent equine influenza vaccination several months before shipment, while others had been vaccinated more than one year earlier. Previous studies have demonstrated the persistence of vaccine-induced antibody responses for up to one year following booster vaccination with some vaccine formulations, although the duration and magnitude of immunity may vary with vaccine type, vaccination history, age, individual immune response, and exposure conditions [20,21]. Therefore, the antibody findings in this investigation are compatible with the reported vaccination histories. However, the qualitative ELISA results do not allow for the assessment of antibody magnitude or protective capacity.

An additional limitation of this investigation was the inability to quantify antibody titres. The sera were not evaluated using the haemagglutination inhibition (HI) test, partly due to the unavailability of receptor-destroying enzyme (RDE). Non-specific inhibitors in equine sera can interfere with HI assays; however, pretreatment with RDE or alternative procedures can mitigate this interference and enhance assay specificity [22]. Furthermore, the ELISA used in this investigation was qualitative and detected antibodies to influenza A virus rather than providing quantitative antibody titres. Therefore, the results cannot establish whether the detected antibody levels were sufficient to provide protective immunity or distinguish between antibodies induced by vaccination and those arising from natural infection. Previous studies have similarly demonstrated limitations in using ELISA to differentiate between infected and vaccinated horses, depending on the vaccine formulation and assay employed [23].

The findings have implications for the interpretation of serological surveillance in imported horses. Detection of EIV antibodies indicates an antibody response to influenza A virus antigens; however, it does not, in isolation, demonstrate active infection or transmission. Therefore, interpretation requires consideration of vaccination history, clinical status, the interval between vaccination and sampling, and, where indicated, results from virological or molecular investigations. In this context, the present findings should not be interpreted as evidence of subclinical EIV infection. Rather, they demonstrate the limitations of relying solely on qualitative serology when evaluating vaccinated horses following international movement.

Nevertheless, post-import surveillance remains a crucial component of equine disease prevention. Routine monitoring provides an opportunity to assess the health status of imported horses, verify vaccination records, and identify animals that require further investigation. This is particularly relevant in Nigeria, where previous serological surveillance has evidenced influenza A virus exposure among horses. In a study conducted in Kaduna State, antibodies to influenza A virus were detected in 173 of 284 horses (60.9%), highlighting the need for continued surveillance of equine influenza and appropriate biosecurity measures for imported horses [24].

The potential consequences of introducing EIV into a susceptible equine population warrant continued attention. Outbreaks associated with the movement of infected horses have occurred across international borders, including major equine influenza outbreaks in South Africa in 1986 and India in 1987 [16,25,26]. These events demonstrate the potential for international horse movement to facilitate EIV spread. The present investigation, however, provides no evidence that transmission occurred among the horses examined. Its principal value lies in demonstrating the need to interpret serological findings in conjunction with vaccination history, clinical assessment, and appropriate virological testing.

Conclusion

Routine post-import screening identified influenza A virus antibodies in six vaccinated polo ponies; however, RT-qPCR showed no evidence of active infection at the time of testing. These findings underscore the importance of interpreting serological results in the context of vaccination history and support the use of post-import screening as a component of equine disease surveillance. Incorporating molecular diagnostics alongside serological testing and clinical assessment may strengthen the detection of active infection in imported horses.

Acknowledgment

We express our sincere appreciation to Mr. Daspan Amos of the Regional Laboratory of Animal Influenza and Transboundary Animal Diseases, National Veterinary Research Institute, Vom, for his technical assistance. 

Conflicts of interest

There are no conflicts of interest associated with this manuscript. The manuscript was read and approved by all authors.

Funding

No external funding was received for the preparation of this manuscript.

References

1. Sack A, Oladunni FS, Gonchigoo B, Chambers TM, Gray GC. Zoonotic diseases from horses: A systematic review. Vector Borne Zoonotic Disease. 2020;20(7):484-495. doi:10.1089/vbz.2019.2541.

2. Shittu I, Meseko CA, Sulaiman LP, et al. Fatal multiple outbreaks of equine influenza H3N8 in Nigeria, 2019: The first introduction of Florida clade 1 to West Africa. Veterinary Microbiology. 2020;248:108820. doi:10.1016/j.vetmic.2020.108820.

3. Dionísio L, Medeiros F, Pequito M, Faustino-Rocha AI. Equine influenza: A comprehensive review from etiology to treatment. Animal Health Research Reviews. 2021;22(1):56-71. doi:10.1017/S1466252321000050.

4. Branda F, Yon DK, Albanese M, et al. Equine influenza: Epidemiology, pathogenesis, and strategies for prevention and control. Viruses. 2025;17(3):302. doi:10.3390/v17030302.

5. Sack A, Cullinane A, Daramragchaa U, Chuluunbaatar M, Gonchigoo B, Gray GC. Equine influenza virus—A neglected, reemergent disease threat. Emerging Infectious Diseases. 2019;25(6):1185.

6. Chambers TM. A brief introduction to equine influenza and equine influenza viruses. Methods Molecular Biology. 2020;2123:355-360. doi:10.1007/978-1-0716-0346-8_26.

7. Singh RK, Dhama K, Karthik K, et al. A comprehensive review on equine influenza virus: Etiology, epidemiology, pathobiology, advances in developing diagnostics, vaccines, and control strategies. Frontiers Microbiology. 2018;9:1941. doi:10.3389/fmicb.2018.01941.

8. Cullinane A, Newton JR. Equine influenza—a global perspective. Veterinary Microbiology. 2013;167(1-2):205-214. doi:10.1016/j.vetmic.2013.03.029.

9. Lascola KM. Equine influenza. In: Merck Veterinary Manual. Respiratory diseases of horses. Merck & Co., Inc.; 2023. Available from: Merck Veterinary Manual.

10. Spackman E, Senne DA, Myers TJ, Bulaga LL, Garber LP, Perdue ML, Lohman K, Daum LT, Suarez DL. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. Journal of Clinical Microbiology. 2002;40(9):3256-3260.

11. Animal Health Australia. 2025. Australian Veterinary Emergency Plan: Equine Influenza. Version 5.0. Available from: Animal Health Australia AVEPLAN [Access date: 29.01.2026].

12. Rosanowski SM, Cogger N, Rogers CW, Stevenson MA. Evaluating the effectiveness of strategies for the control of equine influenza virus in the New Zealand equine population. Transboundary and Emerging Diseases. 2016;63(3):321-332. doi:10.1111/tbed.12277.

13. Watson J, Daniels P, Kirkland P, Carroll A, Jeggo M. The 2007 outbreak of equine influenza in Australia: Lessons learned for international trade in horses. Revue scientifique et technique (International Office of Epizootics). 2011;30(1):87-93. doi:10.20506/rst.30.1.2021.

14. Nemoto M, Kawanishi N, Kamei R, Furusho K, et al. Genetic and serological analyses of equine influenza viruses isolated in Kumamoto and Hokkaido, Japan in 2025. Veterinary Microbiology. 2025;310:110701. doi:10.1016/j.vetmic.2025.110701.

15. Dominguez M, Münstermann S, de la Rua-Domenech R, et al. Equine disease events resulting from international horse movements: systematic review and lessons learned. Equine Veterinary Journal. 2016;48(3):329-335. doi:10.1111/evj.12523.

16. Cullinane A, Elton D, Mumford J. Equine influenza—surveillance and control. Influenza and Other Respiratory Viruses. 2010;4(6):339-344. doi:10.1111/j.1750-2659.2010.00176.x.

17. Chambers TM. Equine influenza. Cold Spring Harbor Perspectives in Medicine. 2022;12(1):a038331. doi:10.1101/cshperspect.a038331.

18. Padalino B, Raidal SL, Carter N, et al. Immunological, clinical, haematological and oxidative responses to long distance transportation in horses. Revue scientifique et technique (International Office of Epizootics). 2017;115:78-87. doi:10.1016/j.rvsc.2017.01.024.

19. Smith FL, Watson JL, Spier SJ, Kilcoyne I, Mapes S, Sonder C, Pusterla N. Frequency of shedding of respiratory pathogens in horses recently imported to the United States. Journal of Veterinary Internal Medicine. 2018;32(4):1436-1441. doi:10.1111/jvim.15145.

20. Gildea S, Arkins S, Walsh C, Cullinane A. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings—a randomised blind study. Vaccine. 2011;29(49):9214-9223. doi:10.1016/j.vaccine.2011.09.101.

21. Newton JR, Townsend HG, Wood JL, Sinclair R, Hannant D, Mumford JA. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8). Equine Vet J. 2000;32(1):65-74. doi:10.2746/042516400777612116

22. Chambers TM, Reedy SE. Equine influenza serological methods. In: Spackman E, editor. Animal Influenza Virus. Methods in Molecular Biology. Vol. 2123. New York: Humana; 2020. doi:10.1007/978-1-0716-0346-8_31.

23. Galvin P, Gildea S, Arkins S, Walsh C, Cullinane A. The evaluation of a nucleoprotein ELISA for the detection of equine influenza antibodies and the differentiation of infected from vaccinated horses (DIVA). Influenza and Other Respiratory Viruses. 2013;7 Suppl 4(Suppl 4):73-80. doi:10.1111/irv.12195

24. Meseko CA, Ehizibolo DO, Nwokike EC, Wungak YS. Serological evidence of equine influenza virus in horse stables in Kaduna, Nigeria. Journal of Equine Science. 2016;27(3):99-105. doi:10.1294/jes.27.99

25. Guthrie AJ, Stevens KB, Bosman PP. The circumstances surrounding the outbreak and spread of equine influenza in South Africa. Revue scientifique et technique (International Office of Epizootics). 1999;18(1):179-185. doi:10.20506/rst.18.1.1155.

26. Timoney PJ. Infectious diseases and the international movement of horses. In: Equine Infectious Diseases. 2007. p. 549-556. doi:10.1016/B978-1-4160-2406-4.50074-0.